11 -5 (43) 2022 — Ergashev K.T., Pulatova Sh.H. — UNSTABLE PROGRESSIVE ANGINA

UNSTABLE PROGRESSIVE ANGINA

Ergashev K.T., Republican Scientific Center for Emergency Medical Assistance Bukhara branch Bukhara State Medical Institute

Pulatova Sh.H. Republican Scientific Center for Emergency Medical Assistance Bukhara branch Bukhara State Medical Institute

Resume

The review presents data on progressive angina pectoris – exacerbation of chronic ischemic heart disease. The risk of sudden death and myocardial infarction in such patients is higher than in those with stable angina. Despite the widespread introduction of modern diagnostic equipment, the emergence of a large number of drugs, the problem of verification and treatment of coronary heart disease (CHD) remains very relevant. In particular, issues related to the diagnosis and treatment of the disease during its exacerbation, the development of myocardial infarction (MI) and sudden death (VS) are of particular importance.IHD is a common disease caused by atherosclerosis of the coronary arteries, as a result of which the balance between oxygen delivery and myocardial demand is disturbed.

Key words: unstable angina, progressive angina pectoris, silent myocardial ischemia, Holter monitoring.

First page

59

Last page

63

For citation: Ergashev K.T., Pulatova Sh.H. UNSTABLE PROGRESSIVE ANGINA //New Day in Medicine 5(43)2022 59-63 https://clck.ru/haUYY

LIST OF REFERENCES:

  1. Кенжаев М.Л., Ризаева М.Ж. (2020). Клиническое течение фибрилляции предсердий у больных ишемической болезнью сердца. //In Наука и инновации-современные концепции (pp. 103-109).
  2. Kenzhaev M.L., Rizaeva M.Zh., Identification of atrial fibrillation predictors in patients with coronary heart disease//New Day in Medicine 2(30)2020 398-401. https://cutt.ly/QvIQm5R
  3. Пулатова Ш.Х. (2019). Особенности тромболитической терапии у больных острым инфарктом миокарда. Вестник экстренной медицины, 12(6).
  4. Mamas M.A., Sperrin M., Watson M.C., Coutts A., Wilde K., Burton C. et al. Do patients have worse outcomes in heart failure than in cancer? A primary care-based cohort study with 10-year follow-up in Scotland: Outcomes in heart failure and cancer. //European Journal of Heart Failure. 2017;19(9):1095–104. DOI: 10.1002/ejhf.822
  5. Rizaeva M.Z. (2022). The clinical course of atrial fibrillation in patients with coronary heart disease. //European journal of molecular medicine, 2(1).
  6. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. //Journal of Chronic Diseases. 1987;40(5):373–83. DOI: 10.1016/0021-9681(87)90171-8
  7. World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. [Internet] Available at: http://www.who.int/vmnis/indicators/haemoglobin/en/
  8. Ponikowski P., Voors A.A., Anker S.D., Bueno H., Cleland J.GF., Coats A.JS. et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. //European Heart Journal. 2016;37(27):2129–200. DOI: 10.1093/ eurheartj/ehw128
  9. Baratova M.S., Ataeva M.A. Modern Ultrasound Methods for Assessing Indicators of The Latent Diastolic Function of The Left Ventricle //International Journal of Pharmaceutical Research. – 2021. – Т. 13. – №. 1.
  10. Baratova M.S., Atayeva M.A. Тhe estimation of heart rhythm disturbances at the left atrial stunding on early stages of remodeling left ventricular //World medicine journal. – 2020. – №. 1. – С. 1.

file

download